Outcomes among patients with breakthrough SARS-CoV-2 infection after vaccination in a high-risk national population
Author:
Funder
U.S. Department of Veterans Affairs
National Institutes of Health
Publisher
Elsevier BV
Subject
General Medicine
Reference17 articles.
1. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N Engl J Med,2021
2. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine;Polack;N Engl J Med,2020
3. BNT162b2 mRNA COVID-19 vaccine in a nationwide mass vaccination setting;Dagan;N Engl J Med,2021
4. National study group for C-V. Effectiveness of the BNT162b2 COVID-19 vaccine against the B.1.1.7 and B.1.351 variants;Abu-Raddad;N Engl J Med,2021
5. Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination;Butt;J Infect,2021
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nirmatrelvir/ritonavir or Molnupiravir for treatment of non-hospitalized patients with COVID-19 at risk of disease progression;PLOS ONE;2024-06-06
2. Evaluation of antibody responses in healthy individuals receiving SARS-CoV-2 inactivated vaccines;Biosafety and Health;2024-06
3. Increased Risk of Breakthrough SARS-CoV-2 Infections in Patients with Colorectal Cancer: A Population-Based Propensity-Matched Analysis;Journal of Clinical Medicine;2024-04-24
4. Th2 and Th17‐associated immunopathology following SARS‐CoV‐2 breakthrough infection in Spike‐vaccinated ACE2‐humanized mice;Journal of Medical Virology;2024-01
5. Evaluation of the Effects of Coronavirus Vaccination Status on Inpatient Demographics and Clinical and Laboratory Data;Cureus;2023-10-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3